Stottlemyer BA - Search Results

1

Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational Studies.

Amatullah N, Stottlemyer BA, Zerfas I, Stevens C, Ozrazgat-Baslanti T, Bihorac A, Kane-Gill SL. Amatullah N, et al. Among authors: stottlemyer ba. Nephron. 2023;147(12):725-732. doi: 10.1159/000531916. Epub 2023 Aug 23. Nephron. 2023. PMID: 37607496 Free PMC article. Review.

2

Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.

Stottlemyer BA, McDermott MC, Minogue MR, Gray MP, Boyce RD, Kane-Gill SL. Stottlemyer BA, et al. Ther Adv Drug Saf. 2023 Jun 12;14:20420986231181334. doi: 10.1177/20420986231181334. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37332887 Free PMC article.

3

Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method.

Stottlemyer BA, Abebe KZ, Palevsky PM, Fried L, Schulman IH, Parikh CR, Poggio E, Siew ED, Gutierrez OM, Horwitz E, Weir MR, Wilson FP, Kane-Gill SL. Stottlemyer BA, et al. Drug Saf. 2023 Jul;46(7):677-687. doi: 10.1007/s40264-023-01312-5. Epub 2023 May 24. Drug Saf. 2023. PMID: 37223847 Free PMC article.

4

Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.

Bounthavong M, Suh K, Li M, Spoutz PM, Stottlemyer BA, Sepassi A. Bounthavong M, et al. Among authors: stottlemyer ba. Subst Abuse Treat Prev Policy. 2021 Oct 20;16(1):80. doi: 10.1186/s13011-021-00415-5. Subst Abuse Treat Prev Policy. 2021. PMID: 34670580 Free PMC article.

5

Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database.

Kim H, Pfeiffer CM, Gray MP, Stottlemyer BA, Boyce RD, Kane-Gill SL. Kim H, et al. Among authors: stottlemyer ba. Respir Care. 2021 Nov;66(11):1739-1745. doi: 10.4187/respcare.08809. Epub 2021 Jun 8. Respir Care. 2021. PMID: 34103383 Free article.

6

A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

Patel NM, Stottlemyer BA, Gray MP, Boyce RD, Kane-Gill SL. Patel NM, et al. Among authors: stottlemyer ba. Cardiovasc Drugs Ther. 2022 Apr;36(2):309-322. doi: 10.1007/s10557-021-07157-3. Epub 2021 Feb 18. Cardiovasc Drugs Ther. 2022. PMID: 33599896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6 results

Search Page